Can higher inspiratory positive airway pressure (IPAP) settings cause lung collapse (pneumothorax)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Higher IPAP Settings and Lung Collapse Risk

Higher IPAP settings do not directly cause pneumothorax in typical clinical practice when used within guideline-recommended ranges, but BiPAP/NIV should be withheld if pneumothorax is already present.

Evidence-Based Pressure Limits and Safety

The American Academy of Sleep Medicine guidelines establish clear safety parameters for IPAP use:

  • Maximum recommended IPAP is 30 cm H₂O for patients ≥12 years and 20 cm H₂O for patients <12 years 1, 2
  • These limits were established through consensus to balance therapeutic efficacy with safety
  • The recommended minimum IPAP-EPAP differential is 4 cm H₂O with a maximum of 10 cm H₂O 2

Pneumothorax Risk: What the Evidence Shows

In Patients WITHOUT Pre-existing Pneumothorax

Research demonstrates that pneumothorax from positive pressure ventilation requires substantially higher pressures than typical IPAP settings:

  • In healthy newborn lungs, pneumothorax occurred at mean PIP of 90.5 ± 15.7 cm H₂O—far exceeding clinical IPAP ranges 3
  • The study concluded that recruitment maneuvers with PIPs <50 cm H₂O appear safe regarding pneumothorax risk 3
  • A neonatal study found pneumothorax incidence of only 3.8% even with aggressive early CPAP protocols, though higher airway pressures were associated with cases 4

Critical Context: Disease State Matters More Than Pressure Alone

The underlying lung pathology is the primary determinant of pneumothorax risk, not IPAP level per se:

  • Patients with interstitial lung disease had significantly higher pneumothorax rates (60% vs 8.6%) during NPPV despite similar IPAP/EPAP settings (10.6/4.1 vs 9.9/4.0 cm H₂O) 5
  • Most pneumothorax cases occurred within the first 10 days of NPPV initiation 5
  • Consolidated, low-compliance lungs with small "baby lung" volumes are at highest risk, as mechanical load concentrates on limited functional tissue 6, 7

When BiPAP MUST Be Stopped

If pneumothorax develops, BiPAP should be withheld regardless of pneumothorax size 8. This is a firm guideline recommendation from the Cystic Fibrosis Foundation, based on concern that positive pressure may worsen the air leak. The caveat is that some patients may require ICU monitoring if they are ventilator-dependent 8.

Mechanism: Why Elevated Pleural Pressure Matters

The concern about positive pressure relates to elevated pleural pressure (Ppl), not IPAP alone:

  • Positive pressure ventilation increases Ppl, which can push lungs against the thoracic wall and increase shear stress 7
  • This contrasts with spontaneous breathing, where negative Ppl pulls lungs away from the chest wall 7
  • In diseased lungs with blebs or bullae, elevated Ppl may theoretically rupture weakened alveolar structures
  • However, elevated Ppl primarily causes airway collapse and hemodynamic effects rather than pneumothorax in most patients 9, 10

Practical Risk Stratification

Higher Risk Patients (Use Caution, Consider Lower Pressures):

  • Interstitial lung diseases (ILD, pulmonary fibrosis)
  • Severe COPD with bullous disease
  • Recent pneumothorax (within 2 weeks)
  • First 10 days of NPPV initiation in any patient

Standard Risk Patients:

  • Obstructive sleep apnea
  • Obesity hypoventilation syndrome
  • Chronic alveolar hypoventilation
  • Neuromuscular disease

Clinical Algorithm for IPAP Titration

  1. Start conservatively: IPAP 8 cm H₂O, EPAP 4 cm H₂O 1, 2
  2. Increase gradually: Minimum 5-minute intervals, 1 cm H₂O increments 2
  3. Monitor for complications: Sudden desaturation, chest pain, asymmetric breath sounds, rising airway pressures
  4. Stay within guidelines: Maximum IPAP 30 cm H₂O (adults), 20 cm H₂O (children <12 years) 1
  5. In high-risk patients: Consider HDU/ICU placement, especially with obesity hypoventilation requiring high EPAP (10-15 cm H₂O range) 11

Common Pitfall

Do not confuse association with causation: Studies showing higher airway pressures in pneumothorax patients may reflect more severe underlying lung disease requiring higher support, rather than pressure causing the pneumothorax 4. The temporal relationship is often unclear—did high pressure cause the pneumothorax, or did worsening lung disease require both higher pressure AND independently lead to pneumothorax?

Bottom Line

Within guideline-recommended IPAP ranges (≤30 cm H₂O adults, ≤20 cm H₂O children), pneumothorax risk is primarily driven by underlying lung pathology rather than pressure settings themselves. However, if pneumothorax occurs, positive pressure must be discontinued until resolved 8.

References

Guideline

best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (nppv) in stable chronic alveolar hypoventilation syndromes.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010

Guideline

clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Research

Positive airway pressure levels and pneumothorax: a case-control study in very low birth weight infants.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2011

Guideline

cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax.

American Journal of Respiratory and Critical Care Medicine, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.